Ganitumab (AMG 479)

ganitumab · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ganitumab (AMG 479), covering 2021-02-21 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) [Phase 2]